Patients with an MI during follow-up had 1.6 (95% CI 1.1 to 2.4) times higher levels of MCP-1 at VH–IVUS study inclusion than event-free patients (p-value 0.01), unaltered by multivariate adjustment (p-value 0.03). This evidence concerns the gene CCL2 and myocardial infarction.